Instil Bio, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for TIL, updated each market day.
TIL AI Sentiment
AI predicts Instil Bio, Inc. Common Stock stock is likely to increase over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Instil Bio, Inc. Common Stock
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
Sector
Exchange
Market Cap
$57,477,246
Cap Tier
Employees
17
Headquarters
DALLAS, TX
Listed Since
March 19, 2021
Website
TIL Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
TIL Volatility
Instil Bio, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
